agmatine has been researched along with Memory Disorders in 10 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
Memory Disorders: Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Agmatine treatment (Day 8-12) in mice showed reduction in the escape latency and time spent in the target quadrant (probe trial) in the MWM test." | 1.72 | Reversal of lipopolysaccharide-induced learning and memory deficits by agmatine in mice. ( Borikar, SP; Danao, KR; Dongare, SI, 2022) |
| "Alzheimer's disease is an age related progressive neurodegenerative disorder characterized by decline in cognitive functions, such as memory loss and behavioural abnormalities." | 1.62 | Evidences for agmatine alterations in Aβ ( Dixit, MP; Kotagale, NR; Rahmatkar, SN; Raut, P; Taksande, BG; Umekar, MJ, 2021) |
| "Agmatine treatment prevented apoptosis and Akt/GSK-3β signaling impairment induced by STZ." | 1.40 | Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption. ( Dianat, M; Farbood, Y; Ghasemi, R; Moosavi, M; Sarkaki, A; Zarifkar, AH, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izadi, S | 1 |
| Rezaei, A | 1 |
| Esmaili, Z | 1 |
| Soukhaklari, R | 2 |
| Moosavi, M | 4 |
| Ostovan, VR | 1 |
| Baberi, N | 1 |
| Farokhi, MR | 1 |
| Moezi, L | 1 |
| Pirsalami, F | 1 |
| Kotagale, N | 1 |
| Rahmatkar, S | 1 |
| Chauragade, S | 1 |
| Dixit, M | 1 |
| Umekar, M | 1 |
| Chopde, C | 1 |
| Taksande, B | 1 |
| Borikar, SP | 1 |
| Dongare, SI | 1 |
| Danao, KR | 1 |
| Dixit, MP | 1 |
| Rahmatkar, SN | 1 |
| Raut, P | 1 |
| Umekar, MJ | 1 |
| Taksande, BG | 1 |
| Kotagale, NR | 1 |
| Zarifkar, AH | 1 |
| Farbood, Y | 1 |
| Dianat, M | 1 |
| Sarkaki, A | 1 |
| Ghasemi, R | 2 |
| Zarifkar, A | 1 |
| Choopani, S | 1 |
| Naghdi, N | 1 |
| Maghsoudi, AH | 1 |
| Maghsoudi, N | 1 |
| Rastegar, K | 1 |
| Lu, W | 1 |
| Dong, HJ | 1 |
| Gong, ZH | 1 |
| Su, RB | 1 |
| Li, J | 1 |
| Gupta, N | 1 |
| Zhang, H | 1 |
| Liu, P | 1 |
| Bhutada, P | 1 |
| Mundhada, Y | 1 |
| Humane, V | 1 |
| Rahigude, A | 1 |
| Deshmukh, P | 1 |
| Latad, S | 1 |
| Jain, K | 1 |
10 other studies available for agmatine and Memory Disorders
| Article | Year |
|---|---|
Agmatine prevents the memory impairment and the dysfunction of hippocampal GSK-3β and ERK signaling induced by aluminum nanoparticle in mice.
Topics: Agmatine; Aluminum; Animals; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Memory Disorders; M | 2023 |
Cholinergic deficit induced memory retrieval impairment and hippocampal CaMKII-alpha deregulation is counteracted by sub-chronic agmatine treatment in mice.
Topics: Agmatine; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Hippocampus; Male; Memory Dis | 2023 |
Involvement of hippocampal agmatine in β
Topics: Agmatine; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Behavior, Animal; Brain-Derived | 2020 |
Reversal of lipopolysaccharide-induced learning and memory deficits by agmatine in mice.
Topics: Agmatine; Animals; Hippocampus; Lipopolysaccharides; Maze Learning; Memory; Memory Disorders; Mice | 2022 |
Evidences for agmatine alterations in Aβ
Topics: Agmatine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Carboxy-Lyases; Cognition Disorders; Hi | 2021 |
Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption.
Topics: Agmatine; Animals; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Caspase 3; Glycogen Synt | 2014 |
Agmatine prevents LPS-induced spatial memory impairment and hippocampal apoptosis.
Topics: Agmatine; Animals; Apoptosis; Hippocampus; Lipopolysaccharides; Male; Maze Learning; Memory Disorder | 2010 |
Agmatine inhibits morphine-induced memory impairment in the mouse step-down inhibitory avoidance task.
Topics: Adrenergic alpha-Antagonists; Agmatine; Analgesics, Opioid; Animals; Avoidance Learning; Dose-Respon | 2010 |
Chronic difluoromethylornithine treatment impairs spatial learning and memory in rats.
Topics: Agmatine; Animals; Antineoplastic Agents; Behavior, Animal; Eflornithine; Enzyme Inhibitors; Hippoca | 2012 |
Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats.
Topics: Agmatine; Animals; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Imidazoline Re | 2012 |